---All---
  • ---All---
  • Accession
  • Catalog #

TFRC AntibodyMouse Monoclonal Antibody (Mab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AM2075b 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AM2075b-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

TFRC Antibody - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP02786
Other AccessionNP_001121620.1
ReactivityHuman
Concentration0.25 mg/ml
IsotypeIgM
Clone Names514CT23.4.1
Calculated MW84871 Da

TFRC Antibody - Additional info

Gene ID 7037
Other Names
TFRC; Transferrin receptor protein 1; T9; p90; CD_antigen=CD71; Transferrin receptor protein 1, serum form
Target/Specificity
Purified His-tagged TFRC protein(Fragment) was used to produced this monoclonal antibody.
Dilution
WB~~1:100~250
Format
Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Euglobin precipitation followed by dialysis against PBS.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
TFRC Antibody is for research use only and not for use in diagnostic or therapeutic procedures.

TFRC Antibody - Protein Information

Name TFRC
Function
Cellular uptake of iron occurs via receptor-mediated endocytosis of ligand-occupied transferrin receptor into specialized endosomes. Endosomal acidification leads to iron release. The apotransferrin-receptor complex is then recycled to the cell surface with a return to neutral pH and the concomitant loss of affinity of apotransferrin for its receptor. Transferrin receptor is necessary for development of erythrocytes and the nervous system (By similarity). A second ligand, the heditary hemochromatosis protein HFE, competes for binding with transferrin for an overlapping C-terminal binding site
Cellular Location
Cell membrane; Single-pass type II membrane protein. Melanosome. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV

TFRC Antibody - Related products

AM2075a: TFRC Antibody (Ascites)

AM2075b: TFRC Antibody

AP2949b: CD71 Antibody (C-term)

RI15296: TFRC predesign siRNA

BP2949b: CD71 Antibody (C-term) Blocking Peptide

AT4226a: TFRC Antibody (monoclonal) (M01)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Cellular uptake of iron occurs via receptor-mediated endocytosis of ligand-occupied transferrin receptor into specialized endosomes. Endosomal acidification leads to iron release. The apotransferrin-receptor complex is then recycled to the cell surface with a return to neutral pH and the concomitant loss of affinity of apotransferrin for its receptor. Transferrin receptor is necessary for development of erythrocytes and the nervous system (By similarity). A second ligand, the heditary hemochromatosis protein HFE, competes for binding with transferrin for an overlapping C-terminal binding site.

REFERENCES

Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010) Ucisik-Akkaya, E., et al. Mol. Hum. Reprod. 16(10):770-777(2010) Blonde-Cynober, F., et al. Ann. Biol. Clin. (Paris) 68(5):569-575(2010) Marsee, D.K., et al. Am. J. Clin. Pathol. 134(3):429-435(2010) Fernandez-Real, J.M., et al. Eur. J. Clin. Invest. 40(7):600-607(2010)